Canadian Cannabis Investor Resources

Did you know as an investor you can capitalize on the growth of legal cannabis in Canada through publicly-traded and private Licensed Producers? Keep track of the legal medical cannabis program overseen by Health Canada and the evolving framework for adult-use.


Licensed since March 2014, ABcann sets itself apart from other Canadian licensed producers with its 94% customer retention rate, its focus on organic cultivation in proprietary growing chambers and its industry-leading production yields in excess of 250 grams per sq. ft., double the industry average. The company is in the process of developing its 65-acre site with a second 150K sq. ft. facility.


Aurora Cannabis, one of 2 licensed producers in Alberta, was the first applicant in the country to construct a purpose-built facility, which can now be described as no less than state-of-the-art. The company is currently constructing a large hybrid greenhouse in advance of higher demand post-legalization, and its innovative e-commerce app and same day delivery help set it apart from its peers.


Canopy Growth Corporation, formerly Tweed Marijuana Inc., is a medical marijuana company based out of Smiths Falls, Ontario. It is the first federally regulated, publicly traded cannabis producer in North America, traded on the Toronto Stock Exchange as WEED. Canopy Growth Corp. is the first multi-licensed, geographically diverse marijuana producer operating a variety of production platforms in Canada.


DOJA™ Cannabis Company is building a premier cannabis lifestyle brand that will feature the highest quality handcrafted strains in Canada. DOJA’s state-of-the-art ACMPR licensed production facility is located in the heart of British Columbia’s picturesque Okanagan Valley. The company was founded by the proven entrepreneurial team that started SAXX Underwear®.


Emblem, a fully integrated Canadian healthcare and pharmaceutical company with the potential in a recreational marijuana market, to be generating $100 million in revenue, is led by a team of healthcare and Big Pharma executives, who have founded and run multi-billion dollar companies and have invested into the company.



Harvest One is a holding company that owns Canadian ACMPR licensed producer United Greeneries and Swiss medical cannabis brand Satipharm. United Greeneries received its cultivation license in June 2016 and is focused on expanding the capacity at it Duncan Facility from about 1000kg per year to about 50,000kg per year to serve both the medical and recreational markets.



Maricann Group, Inc. is an established Canadian licensed producer that is expanding its greenhouse production facility in Ontario and preparing to cultivate cannabis in Germany. The company has partnered with Colorado-based extraction experts Evolab to develop innovative products and has a management team with experience in cultivation, pharmaceuticals, distribution and healthcare.



As the 3rd LP backed by the same financial team that brought together OrganiGram and Emblem Cannabis, Green Organic Dutchman grows the highest quality Organic medical cannabis in small batches using craft growing, all natural and organic principles. With experienced, passionate growers with over 8 years of MMAR growing experience, 25 acres of land, and immediate revenue from wholesale market, Green Organic Dutchman expects to generate $90 million by 2018.


The way individuals access cannabis for medical purposes has changed. As of August 24, 2016, the Access to Cannabis for Medical Purposes Regulations (ACMPR) replaced the Marihuana for Medical Purposes Regulations (MMPR). Use the links found on this page to track rules, regulations and opportunities to capitalize on licensed producers of medical cannabis.

ACMPR Rules
Access to Cannabis for Medical Purposes Regulations

Licenses issued by Health Canada
Authorized Licensed Producers for Medical Purposes

Bill C-45 (to legalize cannabis)
First Reading

MMJ Quarterly Market Data
Marijuana for Medical Purposes

MMJ Quarterly Compliance and Enforcement Report
Inspection Data Summary